Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology.

Tocchetti CG, Farmakis D, Koop Y, Andres MS, Couch LS, Formisano L, Ciardiello F, Pane F, Au L, Emmerich M, Plummer C, Gulati G, Ramalingam S, Cardinale D, Brezden-Masley C, Iakobishvili Z, Thavendiranathan P, Santoro C, Bergler-Klein J, Keramida K, de Boer RA, Maack C, Lutgens E, Rassaf T, Fradley MG, Moslehi J, Yang EH, De Keulenaer G, Ameri P, Bax J, Neilan TG, Herrmann J, Mbakwem AC, Mirabel M, Skouri H, Hirsch E, Cohen-Solal A, Sverdlov AL, van der Meer P, Asteggiano R, Barac A, Ky B, Lenihan D, Dent S, Seferovic P, Coats AJS, Metra M, Rosano G, Suter T, Lopez-Fernandez T, Lyon AR

Open source

DOI: 10.1002/ejhf.3340
Published: 2024 Oct
Container: European journal of heart failure
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ejhf.3340,
  title = {Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology.},
  author = {Tocchetti CG and Farmakis D and Koop Y and Andres MS and Couch LS and Formisano L and Ciardiello F and Pane F and Au L and Emmerich M and Plummer C and Gulati G and Ramalingam S and Cardinale D and Brezden-Masley C and Iakobishvili Z and Thavendiranathan P and Santoro C and Bergler-Klein J and Keramida K and de Boer RA and Maack C and Lutgens E and Rassaf T and Fradley MG and Moslehi J and Yang EH and De Keulenaer G and Ameri P and Bax J and Neilan TG and Herrmann J and Mbakwem AC and Mirabel M and Skouri H and Hirsch E and Cohen-Solal A and Sverdlov AL and van der Meer P and Asteggiano R and Barac A and Ky B and Lenihan D and Dent S and Seferovic P and Coats AJS and Metra M and Rosano G and Suter T and Lopez-Fernandez T and Lyon AR},
  year = {2024},
  journal = {European journal of heart failure},
  doi = {10.1002/ejhf.3340},
  url = {https://doi.org/10.1002/ejhf.3340}
}

RIS

TY  - JOUR
TI  - Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology.
AU  - Tocchetti CG
AU  - Farmakis D
AU  - Koop Y
AU  - Andres MS
AU  - Couch LS
AU  - Formisano L
AU  - Ciardiello F
AU  - Pane F
AU  - Au L
AU  - Emmerich M
AU  - Plummer C
AU  - Gulati G
AU  - Ramalingam S
AU  - Cardinale D
AU  - Brezden-Masley C
AU  - Iakobishvili Z
AU  - Thavendiranathan P
AU  - Santoro C
AU  - Bergler-Klein J
AU  - Keramida K
AU  - de Boer RA
AU  - Maack C
AU  - Lutgens E
AU  - Rassaf T
AU  - Fradley MG
AU  - Moslehi J
AU  - Yang EH
AU  - De Keulenaer G
AU  - Ameri P
AU  - Bax J
AU  - Neilan TG
AU  - Herrmann J
AU  - Mbakwem AC
AU  - Mirabel M
AU  - Skouri H
AU  - Hirsch E
AU  - Cohen-Solal A
AU  - Sverdlov AL
AU  - van der Meer P
AU  - Asteggiano R
AU  - Barac A
AU  - Ky B
AU  - Lenihan D
AU  - Dent S
AU  - Seferovic P
AU  - Coats AJS
AU  - Metra M
AU  - Rosano G
AU  - Suter T
AU  - Lopez-Fernandez T
AU  - Lyon AR
PY  - 2024
JO  - European journal of heart failure
DO  - 10.1002/ejhf.3340
UR  - https://doi.org/10.1002/ejhf.3340
ER  -

APA

CG, T., D, F., Y, K., MS, A., LS, C., L, F., F, C., F, P., L, A., M, E., C, P., G, G., S, R., D, C., C, B., Z, I., P, T., C, S., J, B., K, K., RA, D. B., C, M., E, L., T, R., MG, F., J, M., EH, Y., G, D. K., P, A., J, B., TG, N., J, H., AC, M., M, M., H, S., E, H., A, C., AL, S., P, V. D. M., R, A., A, B., B, K., D, L., S, D., P, S., AJS, C., M, M., G, R., T, S., T, L., & AR, L. (2024). Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology.. European journal of heart failure. https://doi.org/10.1002/ejhf.3340

Source records

pubmed · retrieved 2026-09-26T18:34:39.956Z